TickerFactsScreenerDevelopers

Vera Therapeutics, Inc. (VERA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$34.81M2021: -$23.71M2022: -$67.60M2023: -$92.18M2024: -$134.68M2025: -$241.10M-$241.10M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$241.10M-79.0%
2024-$134.68M-46.1%
2023-$92.18M-36.4%
2022-$67.60M-185.1%
2021-$23.71M+31.9%
2020-$34.81M—